nach oben

Erschienen in:

01.02.2009 | Practical Pearl

Cardiogenic Shock with Stunned Myocardium during Triple-H Therapy Treated with Intra-aortic Balloon Pump Counterpulsation

verfasst von: Fabio Silvio Taccone, Boris Lubicz, Michael Piagnerelli, Marc Van Nuffelen, Jean-Louis Vincent, Daniel De Backer

Erschienen in: Neurocritical Care | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Excessive use of adrenergic agents may result in stunned myocardium.

Cases

We report the cases of two patients with subarachnoid hemorrhage (SAH) complicated by cardiogenic shock secondary to triple-H therapy for cerebral vasospasm. Both patients had normal cardiac function on admission and no signs of acute myocardial infarction at the onset of cardiogenic shock. Intra-aortic balloon pump (IABP) counterpulsation was used to maintain adequate cerebral perfusion while enabling the high doses of norepinephrine that were being administered to be reduced. Reversal of the myocardial dysfunction after vasopressors were discontinued supported a diagnosis of catecholamine-induced stunned myocardium.

Conclusion

IABP counterpulsation may be one therapeutic option for patients with vasospasm after SAH when high doses of vasopressors can induce severe myocardial dysfunction. However, this invasive device may not be sufficient to maintain adequate cerebral perfusion and fatal embolic events can complicate the clinical course.

Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for health care professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1994;90:2592–605.PubMed

Van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249–78. doi:10.1093/brain/124.2.249.CrossRefPubMed

Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123–33. doi:10.1227/01.NEU.0000068863.37133.9E.CrossRefPubMed

Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4:68–76. doi:10.1385/NCC:4:1:068.CrossRefPubMed

Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–96. doi:10.1056/NEJMra052732.CrossRefPubMed

Donaldson JW, Pritz MB. Myocardial stunning secondary to aneurysmal subarachnoid hemorrhage. Surg Neurol. 2001;55:12–6. doi:10.1016/S0090-3019(00)00296-2.CrossRefPubMed

Bulsara KR, McGirt MJ, Liao L, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98:524–8.PubMed

Iltumur K, Tamam Y, Karahan Z, Guzel A, Altindag R. Coexisting subarachnoid hemorrhage and subdural hematoma mimicking acute anterolateral myocardial infarction. J Electrocardiol. 2007;40:422–5. doi:10.1016/j.jelectrocard.2007.05.006.CrossRefPubMed

Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24:636–40.PubMed

10.

Sakr YL, Lim N, Amaral AC, et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2004;96:369–73. doi:10.1016/j.ijcard.2003.07.027.CrossRefPubMed

11.

Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol. 2001;38:11–8. doi:10.1016/S0735-1097(01)01316-X.CrossRefPubMed

12.

Jacob WA, Van Bogaert A, Groodt-Lasseel MH. Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage. J Mol Cell Cardiol. 1972;4:287–98. doi:10.1016/0022-2828(72)90076-4.CrossRefPubMed

13.

Doshi R, Neil-Dwyer G. A clinicopathological study of patients following a subarachnoid hemorrhage. J Neurosurg. 1980;52:295–301.PubMed

14.

Sato K, Masuda T, Kikuno T, et al. Left ventricular asynergy and myocardial necrosis accompanied by subarachnoid hemorrhage: contribution of neurogenic pulmonary edema. J Cardiol. 1990;20:359–67.PubMed

15.

Bolli R. Mechanism of myocardial “stunning”. Circulation. 1990;82:723–38.PubMed

16.

Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609–34.PubMed

17.

Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2004;25:126–9.PubMed

18.

Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36:1328–35. doi:10.1016/S0735-1097(00)00857-3.CrossRefPubMed

19.

Chang PC, Lee SH, Hung HF, Kaun P, Cheng JJ. Transient ST elevation and left ventricular asynergy associated with normal coronary artery and Tc-99m PYP Myocardial Infarct Scan in subarachnoid hemorrhage. Int J Cardiol. 1998;63:189–92. doi:10.1016/S0167-5273(97)00293-3.CrossRefPubMed

20.

Pfister D, Strebel SP, Steiner LA. Effects of catecholamines on cerebral blood vessels in patients with traumatic brain injury. Eur J Anaesthesiol Suppl. 2008;42:98–103.PubMed

21.

Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1993;79:494–9.PubMed

22.

Tavernier B, Decamps F, Vega E, Poidevin P, Verdin M, Riegel B. Systemic treatments of the vasospasm. Ann Fr Anesth Reanim. 2007;26:980–4. doi:10.1016/j.annfar.2007.08.012.PubMed

23.

Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–52.PubMedCrossRef

24.

Higashida RT, Halbach VV, Dowd CF, Dormandy B, Bell J, Hieshima GB. Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results. Neurosurg Rev. 1992;15:89–95. doi:10.1007/BF00313501.CrossRefPubMed

25.

Rosen CL, Sekhar LN, Duong DH. Use of intra-aortic balloon pump counterpulsation for refractory symptomatic vasospasm. Acta Neurochir (Wien). 2000;142:25–32. doi:10.1007/s007010050003.CrossRef

26.

Boehmer JP, Popjes E. Cardiac failure: mechanical support strategies. Crit Care Med. 2006;34:S268–77. doi:10.1097/01.CCM.0000232490.69771.28.CrossRefPubMed

27.

Yoshitani H, Akasaka T, Kaji S, et al. Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coronary arteries. Am Heart J. 2007;154:725–31. doi:10.1016/j.ahj.2007.05.019.CrossRefPubMed

28.

Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol. 2007;19:339–46.PubMed

29.

Schreuder JJ, Maisano F, Donelli A, et al. Beat-to-beat effects of intraaortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Ann Thorac Surg. 2005;79:872–80. doi:10.1016/j.athoracsur.2004.07.073.CrossRefPubMed

30.

Dekker AL, Reesink KD, van der Veen FH, et al. Intra-aortic balloon pumping in acute mitral regurgitation reduces aortic impedance and regurgitant fraction. Shock. 2003;19:334–8. doi:10.1097/00024382-200304000-00007.CrossRefPubMed

31.

Simeone FA, Laurent JP, Trepper PJ, Brown DJ, Cotter J. Experimental augmentation of cerebral blood flow by intermittent aortic occlusion. J Neurosurg. 1972;36:700–13.PubMed

32.

Nussbaum ES, Heros RC, Solien EE, Madison MT, Sebring LA, Latchaw RE. Intra-aortic balloon counterpulsation augments cerebral blood flow in a canine model of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurgery. 1995;36:879–84. doi:10.1097/00006123-199504000-00047.CrossRefPubMed

33.

Tranmer BI, Gross CE, Kindt GW, Adey GR. Pulsatile versus nonpulsatile blood flow in the treatment of acute cerebral ischemia. Neurosurgery. 1986;19:724–31.PubMedCrossRef

34.

Cheung AT, Levy WJ, Weiss SJ, Barclay DK, Stecker MM. Relationships between cerebral blood flow velocities and arterial pressures during intra-aortic counterpulsation. J Cardiothorac Vasc Anesth. 1998;12:51–7. doi:10.1016/S1053-0770(98)90055-6.CrossRefPubMed

35.

Gee W, Smith RL, Perline RK, Gallagher HS. Assessment of intra-aortic balloon pumping by ocular pneumoplethysmography. Am Surg. 1986;52:489–91.PubMed

36.

Bhayana JN, Scott SM, Sethi GK, Takaro T. Effects of intraaortic balloon pumping on organ perfusion in cardiogenic shock. J Surg Res. 1979;26:108–13. doi:10.1016/0022-4804(79)90086-6.CrossRefPubMed

37.

Brass LM. Reversed intracranial blood flow in patients with an intra-aortic balloon pump. Stroke. 1990;21:484–7.PubMed

38.

Nussbaum ES, Sebring LA, Ganz WF, Madison MT. Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study. Neurosurgery. 1998;42:206–13. doi:10.1097/00006123-199801000-00048.CrossRefPubMed

39.

Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery. 1996;38:1056–9. doi:10.1097/00006123-199605000-00042.CrossRefPubMed

40.

Montessuit M, Chevalley C, King J, Faidutti B. The use of intra-aortic counterpulsation balloon for the treatment of cerebral vasospasm and edema. Surgery. 2000;127:230–3. doi:10.1067/msy.2000.102047.CrossRefPubMed

41.

Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ. Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesth Analg. 2004;98:1133–9. doi:10.1213/01.ANE.0000111101.41190.99.CrossRefPubMed

Titel: Cardiogenic Shock with Stunned Myocardium during Triple-H Therapy Treated with Intra-aortic Balloon Pump Counterpulsation
verfasst von: Fabio Silvio Taccone
Boris Lubicz
Michael Piagnerelli
Marc Van Nuffelen
Jean-Louis Vincent
Daniel De Backer
Publikationsdatum: 01.02.2009
Verlag: Humana Press Inc
Erschienen in: Neurocritical Care / Ausgabe 1/2009
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-008-9135-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Cases

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Dantrolene: Mechanisms of Neuroprotection and Possible Clinical Applications in the Neurointensive Care Unit

Massive Tongue Swelling in Refractory Status Epilepticus Treated with High-Dose Pentobarbital

Neurologic Complications of Cancer

Greenfield’s Neuropathology

Implications of Early Versus Late Bilateral Pulmonary Infiltrates in Patients with Aneurysmal Subarachnoid Hemorrhage